Market Overview The Friedreich's ataxia drug market encompasses essential symptomatic management and rehabilitation services that preserve function, prevent complications, and maintain quality of life while disease-modifying therapies remain in development. Current care focuses on managing ataxia-related falls, cardiomyopathy, diabetes, scoliosis, and speech difficulties through...